Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lyon

Showing results (491-500 of 539) with videos related to

Pageof 54
Sort By:
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
JMIR Research Protocols|January 29, 2025
Harnessing Human-Centered Design for Evidence-Based Psychosocial Interventions and Implementation Strategies in Community Settings: Protocol for Redesign to Improve Usability, Engagement, and AppropriatenessAaron R Lyon, Sean A Munson, Michael D Pullmann, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
JAMA|March 7, 2013
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathyAnkur Gulati, Andrew Jabbour, Tevfik F Ismail, et al.
European Heart Journal|February 5, 2020
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registryJosé López-Sendón, Carlos Álvarez-Ortega, Pilar Zamora Auñon, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
Cardiovascular Research|July 20, 2020
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the HeartCarlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, et al.
Science Advances|July 1, 2021
Satellite-based survey of extreme methane emissions in the Permian basinItziar Irakulis-Loitxate, Luis Guanter, Yin-Nian Liu, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Journal of Cardiac Failure|May 22, 2021
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial BiopsyPetar M Seferović, Hiroyuki Tsutsui, Dennis M Mcnamara, et al.
Pageof 54

Showing results (491-500 of 539) with videos related to

Sort By:
Pageof 54
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
JMIR Research Protocols|January 29, 2025
Harnessing Human-Centered Design for Evidence-Based Psychosocial Interventions and Implementation Strategies in Community Settings: Protocol for Redesign to Improve Usability, Engagement, and AppropriatenessAaron R Lyon, Sean A Munson, Michael D Pullmann, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
JAMA|March 7, 2013
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathyAnkur Gulati, Andrew Jabbour, Tevfik F Ismail, et al.
European Heart Journal|February 5, 2020
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registryJosé López-Sendón, Carlos Álvarez-Ortega, Pilar Zamora Auñon, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
Cardiovascular Research|July 20, 2020
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the HeartCarlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, et al.
Science Advances|July 1, 2021
Satellite-based survey of extreme methane emissions in the Permian basinItziar Irakulis-Loitxate, Luis Guanter, Yin-Nian Liu, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Journal of Cardiac Failure|May 22, 2021
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial BiopsyPetar M Seferović, Hiroyuki Tsutsui, Dennis M Mcnamara, et al.
Pageof 54